Catalog No.
Product Name
Application
Product Information
Citations
-
Ester Product
Methyl 3(R,S)-hydroxy-13(Z),16(Z),19(Z)-docosatrienoate is an ester compound known for its role in lipid research. This molecule exhibits biological activity as a fatty acid derivative, making it relevant for studies focusing on lipid metabolism and signaling pathways. It serves as a valuable tool for investigating the biological effects of polyunsaturated fatty acids in various cellular contexts. -
Drug Impurity
Nimesulide impurity 3, or 4-Nitro-2-phenoxyaniline, is a known impurity associated with the synthesis of Nimesulide. This compound is important for quality control and characterization in pharmaceutical research, particularly in the evaluation of drug purity and safety. Its role as a metabolite in toxicological studies makes it relevant for assessing the pharmacokinetics and potential side effects of Nimesulide. -
Drug Impurity
Irbesartan impurity 8 is a known impurity associated with the drug Irbesartan, an angiotensin II receptor antagonist. This compound is primarily used for quality control and analytical purposes in pharmaceutical research and development. Its presence can provide insights into the synthesis and stability of Irbesartan formulations. -
Drug Impurity
Aripiprazole impurity 34 is a chemical impurity associated with the antipsychotic drug Aripiprazole. This compound serves as an important reference standard in pharmaceutical research, particularly in studies focusing on drug composition and quality control. It aids in the assessment of purity levels and can be utilized in stability testing and regulatory submissions. Researchers can leverage this impurity to ensure consistent quality in Aripiprazole formulations. -
Drug Intermediate
(S)-Tetrahydrofuran-3-ylamine is a synthetic intermediate primarily utilized in pharmaceutical synthesis. It serves as a valuable building block for the development of various drug compounds. Its unique structural properties enhance its applicability in creating complex molecular architectures necessary for drug discovery and development. -
Drug Impurity
Budesonide impurity 83, also known as Budesonide 21-butyrate, is a specific impurity derived from Budesonide. Its characterization is essential for ensuring the quality and safety of pharmaceutical formulations. This compound serves as a reference standard in analytical chemistry, assisting in method development and validation for the detection of Budesonide-related substances in drug production. -
Drug Impurity
Leflunomide impurity 4 is a known impurity associated with Leflunomide, an immunomodulatory drug. It is utilized in the study of drug metabolism and pharmacokinetics, facilitating the assessment of purity standards in pharmaceutical formulations. This reagent is essential for quality control and regulatory compliance in drug development processes. -
Drug Impurity
Estradiol Valerate Impurity 5 is a chemical impurity associated with Estradiol Valerate. This compound serves as a critical reference standard for assessing the purity and quality of Estradiol Valerate formulations in pharmaceutical research. It is essential for analytical method development, stability testing, and compliance with regulatory standards in drug manufacturing processes. -
Drug Impurity
Trimetazidine impurity 8 is a known impurity associated with the pharmaceutical compound Trimetazidine. It is used primarily for analytical and research purposes, particularly in the characterization and quality control of Trimetazidine formulations. The identification and quantification of impurities like Trimetazidine impurity 8 are essential for ensuring the safety and efficacy of drug products in compliance with regulatory standards. -
Drug Impurity
Montelukast impurity 1 hydrochloride is a known impurity of the leukotriene receptor antagonist Montelukast hydrochloride. This compound may serve as a reference standard for the assessment of Montelukast's purity in pharmaceutical formulations. Its analysis is crucial for quality control in drug development and regulatory compliance. -
Drug Impurity
Duloxetine impurity 3 hydrobromide is a specific impurity related to Duloxetine hydrobromide, primarily utilized in chemical research and pharmaceutical quality control. Its characterization is crucial for ensuring the purity and safety of Duloxetine formulations. This compound serves as a reference standard in studies focused on drug development, stability testing, and impurity profiling for regulatory compliance. -
Drug Impurity
Salbutamol Impurity 1, also known as Salbutamol Impurity G, is a known impurity associated with the compound Salbutamol. This reagent is utilized primarily in pharmaceutical research to assess the purity and stability of Salbutamol formulations. Its presence is critical for quality control and regulatory compliance in the development of bronchodilator therapies. -
Drug Impurity
Clarithromycin impurity 7, also known as N-Formylclarithromycin, is a recognized impurity of the antibiotic agent Clarithromycin. This compound is utilized primarily in quality control and analytical studies to assess the purity of Clarithromycin formulations. Its presence can affect the efficacy and safety profiles of the primary drug, making it important for pharmaceutical research and development. -
Drug Impurity
2-Oxo-2-(10,13,16-trimethyl-3-oxo-17-(propionyloxy)-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl)ethyl propionate is an impurity associated with Beclomethasone Dipropionate. This compound is utilized primarily in the quality control and characterization of pharmaceutical formulations containing corticosteroids. Its determination is essential for ensuring the purity and efficacy of therapeutic agents in the clinical setting. -
Drug Impurity
Dexamethasone acetate impurity 2, also known as Desoxymetasone 21-Acetate, is identified as a drug impurity associated with Dexamethasone acetate. It serves as a critical reference standard for assessing the purity and quality of pharmaceutical formulations. Research applications include the study of drug stability, formulation development, and regulatory compliance in pharmaceutical manufacturing processes. -
Drug Impurity
Rufinamide impurity 6 is a relevant impurity associated with the antiepileptic drug Rufinamide. This compound may be utilized in analytical research to study the purity and stability of Rufinamide formulations. Its characterization is essential for ensuring compliance with regulatory standards in pharmaceutical development. -
Drug Impurity
Levothyroxine impurity 8 is a known impurity related to Levothyroxine, a synthetic form of the thyroid hormone thyroxine (T4). This compound is crucial for assessing the purity and quality of Levothyroxine in pharmaceutical formulations. It is commonly used in analytical research to ensure compliance with regulatory standards and to investigate the potential effects of impurities on biological activity. -
Drug Impurity
Fenirofibrate impurity 4 is a chemical impurity associated with Fenirofibrate, a lipid-regulating agent. This impurity can be used in analytical studies for purity assessment and quality control during pharmaceutical research and development. Its presence in formulations may affect the overall safety and efficacy profiles of the primary compound, making it crucial for researchers engaged in drug formulation and compliance testing. -
Drug Impurity
Carbamazepine impurity 5 is a known impurity of the anticonvulsant drug Carbamazepine. This compound serves as a reference standard for impurity profiling and quality control in pharmaceutical research. Its characterization is essential for understanding the drug's stability, efficacy, and safety profile in therapeutic applications. -
Drug Impurity
N-Desmethylterbinafine hydrochloride is a drug impurity associated with terbinafine, a well-known antifungal agent. It serves as a key reference compound in analytical chemistry and quality control studies to ensure the purity and safety of pharmaceutical formulations. Its characterization is crucial for understanding the metabolic profile of terbinafine and assessing any potential impact on efficacy or safety in clinical contexts. -
Drug Impurity
Glipizide impurity 1 is a chemically characterized impurity of the antidiabetic drug Glipizide. It is primarily utilized in quality control and analytical studies to ensure the purity and consistency of Glipizide formulations. Researchers may employ this compound to assess the presence of impurities in pharmaceutical development and regulatory compliance. -
Dexamethasone Impurity
1,2-Dihydro dexamethasone is identified as a significant impurity of dexamethasone, a potent synthetic glucocorticoid. This compound serves as a useful reference standard in analytical chemistry, particularly for the development and validation of analytical methods to assess the purity of dexamethasone. Its utilization can enhance the understanding of the formation and implications of dexamethasone impurities in pharmaceutical formulations and research studies. -
Drug Impurity
Hydrocortisone impurity 9 is a specific impurity associated with Hydrocortisone. This compound serves as a critical reference standard for evaluating the purity and quality of Hydrocortisone formulations in pharmaceutical research. It aids in identifying potential contaminants and ensuring compliance with regulatory standards in drug development and production. -
Drug Impurity
Rosuvastatin methyl ester is an impurity associated with the pharmaceutical compound Rosuvastatin. It serves as a by-product in the synthesis of Rosuvastatin, primarily utilized in quality control and analytical studies to ensure the purity of Rosuvastatin formulations. This compound is critical for researchers examining the pharmacological properties and metabolism of statins in lipid regulation studies. -
Drug Impurity
Solifenacin impurity 4 hydrochloride is a drug impurity associated with Solifenacin hydrochloride. This compound serves as a reference standard for quality control and analytical testing in pharmaceutical research. Its characterization is essential for ensuring the integrity of Solifenacin formulations and adherence to regulatory standards. It aids in the investigation of the synthesis and stability of Solifenacin-related substances. -
Drug Impurity
Montelukast impurity 11 is a known impurity associated with Montelukast, a leukotriene receptor antagonist. This compound is essential for quality control and analytical studies in pharmaceutical development, particularly in assessing the purity and stability of Montelukast formulations. The identification and quantification of drug impurities like Montelukast impurity 11 are crucial for ensuring product safety and efficacy in clinical applications. -
Drug Impurity
(1S,cis)-4-(4-Chlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride serves as a significant impurity of Sertraline, a widely administered selective serotonin reuptake inhibitor. This compound is essential for analytical chemistry applications, particularly in the quality control of pharmaceutical formulations containing Sertraline. Its characterization aids in understanding the presence of impurities and their potential impact on drug efficacy and safety. -
Drug Impurity
Clarithromycin impurity 6, also known as Clarithromycin impurity G, is an impurity associated with the antibiotic Clarithromycin. This compound is utilized primarily for quality control and analytical purposes in pharmaceutical research. Its presence and characterization are essential for ensuring the purity and efficacy of Clarithromycin formulations, making it a valuable reagent in drug development and analytical chemistry applications. -
Drug Impurity
Rosuvastatin impurity 50 is a known impurity associated with Rosuvastatin, a potent HMG-CoA reductase inhibitor. This compound is relevant for quality control and analytical studies in pharmaceutical research, particularly in assessing the purity of Rosuvastatin formulations. Its characterization aids in understanding the compound's pharmacological profile and potential effects on drug efficacy and safety. -
Drug Impurity
Aripiprazole impurity 14 is a synthetic byproduct associated with the antidepressant Aripiprazole, primarily serving as a drug impurity reference standard. This compound is utilized in analytical chemistry for method validation and to ensure the quality of pharmaceutical formulations. Its identification and quantification are essential in regulatory compliance and quality control processes within the pharmaceutical industry. -
Drug Impurity
Edoxaban impurity 19 is a synthetic byproduct associated with Edoxaban, an anticoagulant targeting Factor Xa. This impurity can be employed in pharmacokinetic studies and method development for the analysis of Edoxaban in pharmaceutical formulations. Its characterization is crucial for ensuring the quality and safety of Edoxaban products. -
Drug Impurity
Azithromycin impurity 4 is a characterized impurity of the antibiotic Azithromycin. This compound may serve as a reference standard for analytical testing and quality control in pharmaceutical research and development. It is utilized in studies that assess the purity and stability of Azithromycin formulations, ensuring compliance with regulatory standards. -
Drug Impurity
Naproxen impurity 2 is a known impurity associated with the anti-inflammatory drug Naproxen. This compound is essential for analytical applications, including method development and validation in pharmacokinetic studies. Its identification and quantification are critical for ensuring the quality and safety of pharmaceutical formulations containing Naproxen. -
Drug Impurity
Telmisartan impurity 11 is a chemical impurity associated with the drug Telmisartan, which primarily targets the angiotensin II receptor. This impurity is crucial for quality control in pharmaceutical formulations and is employed to assess the purity and stability of Telmisartan during analysis. It serves as an important reference standard in drug development and regulatory compliance, aiding in the evaluation of related substance profiles and impurity thresholds. -
Drug Impurity
Roxithromycin Ep impurity E is a known impurity of the antibiotic Roxithromycin, serving as an important reference compound in chemical research. Its characterization is critical for ensuring the purity and safety of Roxithromycin formulations. Researchers utilize this impurity in stability studies and quality control assessments to adhere to pharmaceutical regulatory standards. -
Drug Impurity
Leflunomide impurity 5 is a known impurity of Leflunomide, a disease-modifying antirheumatic drug (DMARD). This compound is primarily used in the evaluation of drug purity and quality control in pharmaceutical research. Its presence must be monitored during the development and manufacturing processes to ensure compliance with safety and efficacy standards. -
Drug Impurity
Etoricoxib impurity 26 is a detected impurity associated with the non-steroidal anti-inflammatory drug Etoricoxib. It serves as a valuable reference compound for quality control and analytical studies in pharmaceutical research. This impurity can be utilized to investigate the stability, pharmacokinetics, and metabolic profile of Etoricoxib in various formulations. Understanding such impurities is critical for ensuring the safety and efficacy of pharmaceutical compounds. -
Drug Impurity
Glipizide impurity 10 is a known impurity of the antidiabetic agent Glipizide, primarily affecting its pharmacological profile. This compound is utilized in analytical and quality control settings to assess the purity of Glipizide formulations. Its presence can impact the efficacy and safety of Glipizide in therapeutic applications, making it an important analyte for pharmaceutical research and development. -
Drug Impurity
Citalopram impurity 2 hydrochloride, also known as (rac)-Didemethyl citalopram hydrochloride, is an identified impurity of Citalopram hydrochloride. This compound is utilized in analytical research for the characterization and quality control of Citalopram formulations. Understanding its presence in pharmaceutical formulations helps in ensuring the integrity and safety of drug products. -
Drug Impurity
Haloperidol impurity 1 hydrochloride is a chemical impurity associated with Haloperidol hydrochloride. This compound plays a crucial role in analytical research, particularly in the evaluation of drug purity and quality control within pharmaceutical formulations. Its characterization may aid in understanding the stability and efficacy of Haloperidol-based therapies, making it valuable for researchers in the field of medicinal chemistry. -
Drug Impurity
Testosterone impurity 9 is a chemical byproduct associated with Testosterone synthesis. As a drug impurity, it serves as an important analytical reference for quality control in pharmaceutical formulations. Its identification and quantification are essential for ensuring the purity and efficacy of Testosterone-containing products in research and development settings. -
Drug Impurity
Raloxifene impurity 5 is a chemical impurity associated with Raloxifene, a selective estrogen receptor modulator. This impurity is essential in the analysis and characterization of Raloxifene, particularly in assessing the purity and quality of pharmaceutical formulations. It serves as a reference standard in drug development and regulatory submissions, ensuring compliance with safety and efficacy guidelines. -
Drug Impurity
Lamivudine impurity 1 is identified as a chemical impurity associated with the antiviral agent Lamivudine. This compound serves as a critical reference standard for analytical purposes in pharmaceutical research and quality control. Its study is essential for evaluating the purity of Lamivudine formulations and ensuring compliance with industry standards. -
Drug Impurity
Dicyclomine impurity 1 is identified as an impurity associated with Dicyclomine, a medication primarily used as an antispasmodic. This compound is of significance in pharmaceutical research and quality control, serving as a reference standard for evaluating drug purity and stability. Its characterization is critical for ensuring the safety and efficacy of Dicyclomine formulations in clinical applications. -
Drug Impurity
Salbutamol impurity 15 is a chemical impurity related to the asthmatic treatment agent Salbutamol. It serves as a critical reference standard for the analysis of Salbutamol formulations and assessments of drug quality. This compound is vital for understanding the stability and purity of Salbutamol during pharmaceutical development and quality control processes. -
Drug Impurity
Rivastigmine impurity 10 is a chemical impurity associated with the acetylcholinesterase inhibitor, Rivastigmine. This compound is primarily used for quality control and analytical purposes in pharmaceutical research. It is important for assessing the purity of Rivastigmine in formulations and ensuring compliance with regulatory standards. -
Drug Impurity
Trimetazidine impurity 7 is a chemical impurity associated with Trimetazidine, a drug commonly used in cardiovascular therapy. Its presence may be relevant for analytical and quality control studies in pharmaceutical development. This impurity can serve as a reference standard for the assessment of drug purity and stability, ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Glipizide impurity 12 is a chemical impurity associated with Glipizide, a medication commonly used to manage type 2 diabetes. It serves as a reference standard in pharmaceutical research and quality control, aiding in the assessment of drug purity and stability. This compound is essential for ensuring compliance with regulatory standards and for conducting analytical methods related to Glipizide formulations. -
Drug Impurity
Hydroquinone Impurity 1 is a chemical impurity associated with Hydroquinone, primarily identified in pharmaceutical formulations. Its presence may impact drug efficacy and safety profiles, making it significant in quality control and analytical chemistry. Research applications include assessing drug purity and evaluating the stability of Hydroquinone-containing compounds. -
Drug Intermediate
Ethyl 4-methyl-2-(2-thienyl)-thiazole-5 carboxylate is a synthetic intermediate primarily utilized in pharmaceutical synthesis. Its unique thiazole and thienyl structure make it a valuable building block for the development of various pharmacologically active compounds. This reagent is essential for researchers exploring novel drug formulations and mechanisms of action in drug discovery.
